
The adeno-associated virus (AAV) can be delivered orally because the vaccine is not broken down by stomach acids. In test trials on animals, 100 percent of the subjects had no tumors after one year.

The adeno-associated virus (AAV) can be delivered orally because the vaccine is not broken down by stomach acids. In test trials on animals, 100 percent of the subjects had no tumors after one year.